M&A Deal Summary

Sinclair Pharmaceuticals Acquires Ashbourne Pharmaceuticals

On October 9, 2006, Sinclair Pharmaceuticals acquired life science company Ashbourne Pharmaceuticals from Montagu for 2M USD

Acquisition Highlights
  • This is Sinclair Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Sinclair Pharmaceuticals’ largest (disclosed) transaction.
  • This is Sinclair Pharmaceuticals’ 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2006-10-09
Target Ashbourne Pharmaceuticals
Sector Life Science
Buyer(s) Sinclair Pharmaceuticals
Sellers(s) Montagu
Deal Type Add-on Acquisition
Deal Value 2M USD

Target

Ashbourne Pharmaceuticals

Northampton, United Kingdom
Ashbourne Pharmaceuticals provides Pharmaceuticals services.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sinclair Pharmaceuticals

London, United Kingdom
Category Company
Sector Life Science
DESCRIPTION

Sinclair Pharmaceuticals Ltd. is an international specialty pharma company, with corporate headquarters in London, UK, and operations headquarters in Paris, France.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 3
Country (United Kingdom) 1 of 1
Year (2006) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-15 Advanced Bio-Technologies

Suwanee, Georgia, United States

Advanced Bio-Technologies, Inc. is a privately held dermatological products company that markets Kelo-cote, a patented, self-drying, silicone-based range of products for scar prevention and treatment. ABT’s flagship product, Kelo-cote Advanced Formula Scar Gel, is a proprietary silicone technology used to treat and prevent abnormal scarring such as keloid, burn and hypertrophic scars.

Buy -

Seller(S) 1

SELLER

Montagu

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1968
PE ASSETS 11.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Montagu is an independent private equity firm focused on European management buyouts and growth capital transactions. The Firm seeks opportunities valued between €100 million and €1 billion. Sectors of interest include healthcare, medical products, financial services, software, IT, information services, and education. Montagu dates back to 1968 and is based in London.

DEAL STATS #
Overall 39 of 76
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 17 of 31
Country (United Kingdom) 28 of 41
Year (2006) 7 of 7
Size (of disclosed) 25 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-10-01 British Car Auctions

Hindhead, United Kingdom

BCA is Europe's vehicle remarketing business, providing physical and electronic vehicle auctions, together with a range of e-commerce activities and other related services. BCA operates out of 40 sites in 11 countries and generates gross auction proceeds of GBP3.3 billion per annum.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-06 Unifeeder A/S

Aarhus, Denmark

Unifeeder A/S is an integrated logistics company with the largest and best connected feeder and growing shortsea network in Northern Europe with connectivity to approximately 100 ports. The company provides efficient and sustainable transport solutions for international container shipping lines between international and regional ports and shortsea services to cargo owners with fully multimodal door-to-door solutions, combining seaborne transportation with road and/or rail. The business is cash generative and operates on a highly flexible cost base.

Buy -
Mergr

Product

Company

Legal